Rishi Gupta

This profile gathers the share dealings of Rishi Gupta across 4 companies, led by Verona Pharma plc, Enliven Therapeutics, Inc. and Dimension Therapeutics, Inc. The record holds 20 filings, for trades running from 27 October 2015 to 8 August 2025.

Market trades split into 2 purchases (€6.8M) and 11 sales (€158.4M). Sales outweigh purchases by €151.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 1 option exercise.

Most recently, on 8 August 2025, the filings show a transaction in Turnstone Biologics Corp. The latest purchase dates back some time: it was published 1,188 days ago, on 24 July 2023. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.